HER2 expression predicts improved survival in patients with cervical node-positive head and neck squamous cell carcinoma

Otolaryngology - Head and Neck Surgery

Volumn 141, Issue 4, 2009, Pages 467-473

  Tse, Gary M ^a   Yu, Kwok Hung ^a   Chan, Anthony W H ^a   King, Ann D ^a   Chen, George G ^a   Wong, Ka Tak ^a   Tsang, Raymond K Y ^a   Chan, Amy B W ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P63;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; JAW CANCER; LARYNX CARCINOMA; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUS CARCINOMA; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PREDICTION; PROGNOSIS; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; PROGNOSIS; RECEPTOR, ERBB-2; SURVIVAL ANALYSIS; SURVIVAL RATE; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 70349321265     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2009.06.747     Document Type: Article

References (19)

1. Crowe D.L., Hacia J.G., Hsieh C.L., et al. Molecular pathology of head and neck cancer. Histol Histopathol 17 (2002) 909-914
2. Takeda T., Sugihara K., Hirayama Y., et al. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias. J Oral Pathol Med 35 (2006) 369-375
3. Zangen R., Ratovitski E., and Sidransky D. DeltaNp63alpha levels correlate with clinical tumor response to cisplatin. Cell Cycle 4 (2005) 1313-1315
4. Rocco J.W., Leong C.O., Kuperwasser N., et al. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9 (2006) 45-56
5. Michaud W.A., Nichols A.C., Mroz E.A., et al. Bcl2 blocks cisplatin induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. Clin Cancer Res 15 (2009) 1645-1654
6. Khademi B., Shirazi F.M., Vasei M., et al. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer Lett 184 (2002) 223-230
7. Akamatsu M., Matsumoto T., Oka K., et al. c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 57 (2003) 1323-1327
8. Khan A.J., King B.L., Smith B.D., et al. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 8 (2002) 540-548
9. Fong Y., Chou S.J., Hung K.F., et al. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan. J Chin Med Assoc 71 (2008) 123-127
10. Cavalot A., Martone T., Roggero N., et al. Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas. Head Neck 29 (2007) 655-664
11. Parise Junior O., Carvalho L.V., Miguel R.E., et al. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma. Sao Paulo Med J 122 (2004) 264-268
12. Yu D., Wang S.S., Dulski K.M., et al. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res 54 (1994) 3260-3266
13. Spencer K.S., Graus-Porta D., Leng J., et al. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J Cell Biol 148 (2000) 385-397
14. O-charoenrat P., Rhys-Evans P.H., Modjtahedi H., et al. The role of c-erbB receptors and ligands in head and neck squamous cell carcinoma. Oral Oncol 38 (2002) 627-640
15. Rait A.S., Pirollo K.F., Ulick D., et al. HER-2 targeted antisense oligonucleotide results in sensitization of head and neck cancer cells to chemotherapeutic agents. Ann New York Acad Sci 1002 (2003) 78-89
16. Bortoluzzi M.C., Yurgel L.S., Dekker N.P., et al. Assessment of p63 expression in oral squamous cell carcinomas and dysplasias. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 698-704
17. Barbieri C.E., Tang L.J., Brown K.A., et al. Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 66 (2006) 7589-7597
18. Rocco J.W., and Ellisen L.W. p63 and p73: life and death in squamous cell carcinoma. Cell Cycle 5 (2006) 936-40
19. Thurfjell N., Coates P.J., Vojtesek B., et al. Endogenous p63 acts as a survival factor for tumour cells of SCCHN origin. Int J Mol Med 16 (2005) 1065-1070